BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30009128)

  • 1. Amyloid pathology fingerprint differentiates post-traumatic stress disorder and traumatic brain injury.
    Mohamed AZ; Cumming P; Srour H; Gunasena T; Uchida A; Haller CN; Nasrallah F;
    Neuroimage Clin; 2018; 19():716-726. PubMed ID: 30009128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tauopathy in veterans with long-term posttraumatic stress disorder and traumatic brain injury.
    Mohamed AZ; Cumming P; Götz J; Nasrallah F;
    Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1139-1151. PubMed ID: 30617964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.
    Marcolini S; Rojczyk P; Seitz-Holland J; Koerte IK; Alosco ML; Bouix S;
    J Alzheimers Dis; 2023; 95(4):1427-1448. PubMed ID: 37694363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traumatic brain injury fast-forwards Alzheimer's pathology: evidence from amyloid positron emission tomorgraphy imaging.
    Mohamed AZ; Nestor PJ; Cumming P; Nasrallah FA;
    J Neurol; 2022 Feb; 269(2):873-884. PubMed ID: 34191080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-reported traumatic brain injury and in vivo measure of AD-vulnerable cortical thickness and AD-related biomarkers in the ADNI cohort.
    Wang ML; Wei XE; Yu MM; Li PY; Li WB;
    Neurosci Lett; 2017 Aug; 655():115-120. PubMed ID: 28689050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparing neuropsychological, typical, and ADNI criteria for the diagnosis of mild cognitive impairment in Vietnam-era veterans.
    Ly MT; Adler J; Ton Loy AF; Edmonds EC; Bondi MW; Delano-Wood L;
    J Int Neuropsychol Soc; 2024 Jun; 30(5):439-447. PubMed ID: 38263745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau, β-Amyloid, and Glucose Metabolism Following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS).
    Cummins TL; Doré V; Feizpour A; Krishnadas N; Bourgeat P; Elias A; Lamb F; Williams R; Hopwood M; Landau S; Villemagne VL; Weiner M; Rowe CC
    J Neurotrauma; 2023 Jun; 40(11-12):1086-1097. PubMed ID: 36855333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Traumatic Brain Injury and Post-Traumatic Stress Disorder and Their Influence on Development and Pattern of Alzheimer's Disease Pathology in Later Life.
    Mueller SG
    J Alzheimers Dis; 2024; 98(4):1427-1441. PubMed ID: 38552112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of traumatic brain injury and posttraumatic stress disorder on Alzheimer's disease in veterans, using the Alzheimer's Disease Neuroimaging Initiative.
    Weiner MW; Veitch DP; Hayes J; Neylan T; Grafman J; Aisen PS; Petersen RC; Jack C; Jagust W; Trojanowski JQ; Shaw LM; Saykin AJ; Green RC; Harvey D; Toga AW; Friedl KE; Pacifico A; Sheline Y; Yaffe K; Mohlenoff B;
    Alzheimers Dement; 2014 Jun; 10(3 Suppl):S226-35. PubMed ID: 24924673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White Matter Alterations Are Associated With Cognitive Dysfunction Decades After Moderate-to-Severe Traumatic Brain Injury and/or Posttraumatic Stress Disorder.
    Mohamed AZ; Cumming P; Nasrallah FA;
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Nov; 6(11):1100-1109. PubMed ID: 33957321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Traumatic brain injury and post-traumatic stress disorder are not associated with Alzheimer's disease pathology measured with biomarkers.
    Weiner MW; Harvey D; Landau SM; Veitch DP; Neylan TC; Grafman JH; Aisen PS; Petersen RC; Jack CR; Tosun D; Shaw LM; Trojanowski JQ; Saykin AJ; Hayes J; De Carli C;
    Alzheimers Dement; 2022 Jun; ():. PubMed ID: 35768339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
    Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-reported Fatigue was Associated with Increased White-matter Alterations in Long-term Traumatic Brain Injury and Posttraumatic Stress Disorder Patients.
    Mohamed AZ; Lagopoulos J; Nasrallah FA; Shan Z;
    Neuroscience; 2023 Jun; 520():46-57. PubMed ID: 37080447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Precuneus - A Witness for Excessive Aβ Gathering in Alzheimer's Disease Pathology.
    Aghakhanyan G; Vergallo A; Gennaro M; Mazzarri S; Guidoccio F; Radicchi C; Ceravolo R; Tognoni G; Bonuccelli U; Volterrani D
    Neurodegener Dis; 2018; 18(5-6):302-309. PubMed ID: 30814473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
    Koychev I; Gunn RN; Firouzian A; Lawson J; Zamboni G; Ridha B; Sahakian BJ; Rowe JB; Thomas A; Rochester L; Ffytche D; Howard R; Zetterberg H; MacKay C; Lovestone S;
    J Alzheimers Dis; 2017; 60(1):283-293. PubMed ID: 28800330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.
    Krance SH; Cogo-Moreira H; Rabin JS; Black SE; Swardfager W;
    J Neurosci; 2019 Sep; 39(37):7428-7437. PubMed ID: 31350262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau Imaging in Late Traumatic Brain Injury: A [
    Vanderlinden G; Michiels L; Koole M; Lemmens R; Liessens D; Van Walleghem J; Depreitere B; Vandenbulcke M; Van Laere K
    J Neurotrauma; 2024 Feb; 41(3-4):420-429. PubMed ID: 38038357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.